|
Characteristic
|
Disease stage
|
Total patient population (n)
|
|---|
|
ND (n = 1599)
|
HD (n = 1408)
|
PD (n = 336)
|
|---|
|
Age, years
|
72.02 ± 12.78
|
65.76 ± 12.64
|
62.63 ± 13.50
|
3345
|
|
Male, n (%)
|
875 (54.72)
|
866 (61.50)
|
216 (64.28)
|
3345
|
|
Primary diagnosis, n (%)
|
|
Chronic glomerulonephritis
|
390 (24.39)
|
524 (37.21)
|
113 (33.63)
|
1027
|
|
Diabetic nephropathy
|
551 (34.45)
|
529 (37.57)
|
123 (36.60)
|
1205
|
|
Nephrosclerosis
|
417 (26.07)
|
158 (11.22)
|
47 (13.98)
|
622
|
|
Other
|
240 (15.00)
|
197 (13.99)
|
53 (15.77)
|
490
|
|
Previous ESA therapy, n (%)
|
|
Any
|
809 (50.59)
|
1284 (91.19)
|
263 (78.27)
|
2357
|
|
Erythropoietin
|
286 (17.88)
|
664 (47.15)
|
32 (9.52)
|
982
|
|
Darbepoetin α
|
523 (32.70)
|
620 (44.03)
|
231 (68.75)
|
1375
|
|
Duration of dialysis, years
|
–
|
6.78 ± 7.06
|
2.18 ± 2.47
| |
|
Hb, g/dL
|
9.68 ± 1.12
|
10.27 ± 1.18
|
10.15 ± 1.28
|
3191
|
|
eGFR, mL/min/1.73 m2
|
18.55 ± 11.82
|
–
|
5.56 ± 2.81
| |
|
Serum creatinine, mg/dL
|
3.43 ± 2.12
|
–
|
9.21 ± 3.32
| |
|
Albumin, g/dL
|
3.66 ± 0.55
|
3.65 ± 0.42
|
3.29 ± 0.49
|
2837
|
|
Ferritin, ng/mL
|
162.75 ± 188.51
|
144.38 ± 179.77
|
159.45 ± 126.12
|
1636
|
|
TSAT, %
|
28.91 ± 13.20
|
25.38 ± 11.72
|
34.54 ± 13.34
|
1508
|
- All values are presented as mean ± standard deviation unless otherwise stated
- eGFR estimated glomerular filtration rate, ESA erythropoietin-stimulating agent, Hb hemoglobin, HD hemodialysis, ND not on dialysis, PD peritoneal dialysis, TSAT transferrin saturation
